Goldman Sachs’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$596M Sell
1,234,152
-145,962
-11% -$38.7M 0.05% 345
2026
Q1
$151M Buy
1,380,114
+67,187
+5% +$9.57M 0.02% 817
2025
Q4
$218M Buy
1,312,927
+858,693
+189% +$144M 0.03% 604
2025
Q3
$88.9M Sell
454,234
-153,735
-25% -$25.3M 0.01% 1022
2025
Q2
$55M Buy
607,969
+160,140
+36% +$12.7M 0.01% 1273
2025
Q1
$26.7M Buy
447,829
+121,856
+37% +$11.3M ﹤0.01% 1752
2024
Q4
$43.2M Sell
325,973
-241,855
-43% -$22.7M 0.01% 1427
2024
Q3
$29.7M Sell
567,828
-469,846
-45% -$22.1M ﹤0.01% 1692
2024
Q2
$62.8M Buy
+1,037,674
New +$72M 0.01% 1013

Other funds holding ALAB

Goldman Sachs's ALAB Position: Q2 2026 in Review

Goldman Sachs reduced its Astera Labs (ALAB) stake by 11% in Q2 2026, selling an estimated $38.7M and leaving 1,234,152 shares worth $596M. The position accounts for 0.05% of the portfolio, ranked #345.

Goldman Sachs first reported a position in ALAB in Q2 2024 and has held it in 9 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Goldman Sachs held 1,234,152 shares of Astera Labs worth $596M as of Q2 2026.
  • Goldman Sachs sold 145,962 Astera Labs shares in Q2 2026, an estimated $38.7M.
  • Astera Labs made up 0.05% of Goldman Sachs's portfolio in Q2 2026, its #345 holding.
  • Goldman Sachs first reported a position in Astera Labs in Q2 2024 and has held it in 9 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.